What is Hantavirus? Symptoms, Transmission Routes, and Preventive Measures

Table of Contents

• What is Hantavirus?
• How is Hantavirus transmitted?
• What are the symptoms of Hantavirus?
• Is Hantavirus present in Turkey?
• What is the outbreak on the MV Hondius vessel?
• Is there a treatment for Hantavirus?
• How can one be protected from Hantavirus?
• When should a doctor be consulted?
• Other frequently asked questions

What is Hantavirus?

Hantavirus is a group of RNA viruses belonging to the Bunyaviridae family, whose natural reservoir is rodents. While the virus typically does not manifest disease symptoms in its carrier rodents, it can cause severe infections upon transmission to humans. Over thirty distinct species have been identified within the Hantaviridae family, each associated with a specific rodent species.

The virus was first identified during an outbreak in the "Four Corners" region of the southwestern United States in 1993. It was established that the virus is transmitted to humans via aerosolized particles containing rodent urine, feces, and saliva.

• Yosemite Outbreak: An outbreak in Yosemite National Park in 2012 resulted from the transmission of the virus from deer mice to humans.
• Associated Pathologies: Hantaviruses carried by rodents can induce severe respiratory tract infections known as Hantavirus Pulmonary Syndrome (HPS), as well as Hemorrhagic Fever with Renal Syndrome (HFRS).

How is Hantavirus Transmitted?

Hantavirus is most frequently transmitted to humans via indirect contact with the excreta of infected rodents. The primary mechanism of viral dissemination is the inhalation of dried, aerosolized particles of rodent urine and feces. Consequently, spaces that have remained closed for extended periods (such as warehouses, barns, haylofts, summer houses, and cabins) constitute significant high-risk environments.

Primary routes of transmission:

• Aerosol route: The drying, aerosolization, and subsequent inhalation of rodent urine and feces. This is the most prevalent route of transmission.
• Direct contact: Bites or scratches from an infected rodent.
• Contact with contaminated surfaces: Touching the mouth, nose, or eyes following contact with virus-laden surfaces.
• Consumption of contaminated food or water (rare).

Is there a risk of human-to-human transmission?

As a general rule, hantaviruses are not transmitted from person to person. The sole exception is the Andes strain, endemic to South America; limited human-to-human transmission has been documented in cases of close, prolonged contact (e.g., intrafamilial exposure, healthcare workers, intimate partners). This risk does not apply to the strains circulating in Turkey, Europe, and Asia.

Risk Groups:

• Farmers and individuals engaged in animal husbandry (exposure to haylofts and barns)
• Forestry, agricultural, and port workers
• Hunters and outdoor sports enthusiasts (utilization of cabins and tents)
• Military personnel and laboratory staff
• Individuals conducting cleaning operations in buildings that have been closed for prolonged durations
• Residents of rural areas (particularly during the spring and autumn seasons)

What are the Symptoms of Hantavirus?

Hantavirus symptomatology typically follows a biphasic clinical course. The incubation period varies according to the viral strain, generally ranging from 1 to 8 weeks; however, in the majority of cases, symptoms manifest 2-4 weeks post-exposure.

Early-stage symptoms (first 3-7 days):

• Sudden onset of high fever and chills
• Severe headache
• Myalgia, concentrated primarily in the hips, back, and lower extremities
• Profound fatigue and lethargy
• Nausea, vomiting, and abdominal pain
• Occasional diarrhea

These initial symptoms are easily misdiagnosed as influenza or gastroenteritis. Therefore, in patients presenting with an influenza-like illness and a history of rodent exposure, the possibility of hantavirus infection must be rigorously evaluated.

Late-stage symptoms (after 4-10 days):

At this juncture, the disease progression bifurcates based on the specific viral strain:

Symptoms of HPS (Pulmonary form):

• Dyspnea and tachypnea
• Fluid accumulation in the lungs (pulmonary edema)
• Dry cough progressing to productive cough
• Hypotension and clinical shock
• Acute Respiratory Distress Syndrome (ARDS)

The HPS clinical picture is rapidly progressive and carries a mortality rate of approximately 38%. The Andes and Sin Nombre strains exhibit the highest mortality rates.

Symptoms of HFRS (Renal form):

• Significant reduction in urine output (oliguria)
• Acute renal failure
• Erythema on the face, neck, and back
• Periorbital edema and conjunctival injection
• Hypotension and shock
• Bleeding diathesis secondary to thrombocytopenia (subcutaneous hemorrhages, epistaxis)

The mortality rate for HFRS varies by strain: 5-15% for the Hantaan virus, less than 1% for the Puumala virus, and 10-12% for the Dobrava virus. Cases observed in Turkey generally present with Puumala-like strains and manifest as relatively milder clinical scenarios.

Is Hantavirus Present in Turkey?

Yes, hantavirus cases are documented in Turkey. According to data from the General Directorate of Public Health of the Turkish Ministry of Health, rodent-borne hantavirus cases have been registered in various provinces, predominantly in the Western Black Sea region, since 2009.

Cases in Turkey are primarily of the HFRS (renal syndrome) form; thus, they present with a clinical picture affecting renal functions. These cases generally peak during the spring and autumn seasons, correlating with periods of heightened rodent activity.

Specific considerations for hantavirus in Turkey:

• Individuals performing cleaning tasks in haylofts, barns, and warehouses in rural areas constitute the primary risk cohort.
• Summer houses situated in the highlands (yaylas) and forested regions of the Black Sea region can serve as significant points of exposure.
• The hantavirus strains endemic to Turkey do not transmit from person to person.
• The Andes strain, identified on the MV Hondius vessel, is not present in Turkey.

What is the MV Hondius Hantavirus Outbreak?

In early May 2026, a hantavirus outbreak emerged on the Dutch-flagged passenger vessel MV Hondius. The ship had departed from the port of Ushuaia, Argentina, on April 1, 2026, and en route to Cabo Verde, cases of severe respiratory illness were observed among the passengers.

Key details regarding the outbreak:

• Out of a total of 147 individuals (passengers and crew) onboard, 5 confirmed cases, 3 suspected cases, and 3 fatalities were reported as of May 6, 2026.
• The cases were attributed to the Andes strain, which is the only hantavirus species capable of limited human-to-human transmission.
• It is assessed that the Dutch couple, presumed to be the index cases, contracted the virus during a bird-watching excursion while on a four-month caravan tour traversing Chile, Uruguay, and Argentina prior to boarding the vessel.
• Following the denial of its request to dock in Tenerife, the vessel anchored off the port of Praia, Cabo Verde; the infected patients were subsequently transported to the Netherlands via medical evacuation flights.

Global public health implications of the outbreak:

• In a statement dated May 7, 2026, WHO Director-General Tedros Adhanom Ghebreyesus emphasized that the global public health risk remains low, asserting: "This is not the dawn of a novel COVID pandemic".
• Human-to-human transmission of the Andes strain is only plausible through close and prolonged contact, a dynamic that is in no way comparable to the rapid respiratory spread of COVID-19.
• Both the European Centre for Disease Prevention and Control (ECDC) and the Africa CDC have announced that they are closely monitoring the outbreak and have initiated contact tracing for passengers who disembarked from the vessel.
• No cases linked to this outbreak have been reported in Turkey.

Is there a Treatment for Hantavirus?

There is currently no approved specific antiviral therapy or vaccine for hantavirus infection. Management relies on supportive care aimed at preserving the patient's vital functions.

Supportive care modalities:

• Hemodynamic monitoring in an intensive care setting
• Respiratory support (oxygen therapy, mechanical ventilation in advanced cases, extracorporeal membrane oxygenation/ECMO)
• Meticulous management of fluid and electrolyte balance
• Dialysis support for acute renal failure in HFRS cases
• Blood pressure monitoring and the administration of vasopressors when indicated

There is some data suggesting that the early administration of the antiviral drug ribavirin may positively influence the clinical course in certain HFRS cases; however, this is not a standard of care and is not administered uniformly. The efficacy of ribavirin in HPS cases has not been demonstrated.

Early diagnosis and prompt intensive care support are the most critical determinants of survival in hantavirus infections. Therefore, it is imperative that individuals with a history of high-risk exposure who develop influenza-like symptoms seek immediate medical attention.

How Can One Be Protected from Hantavirus?

Given the absence of an approved vaccine, the cornerstone of prevention is rodent control and the mitigation of exposure.

Precautions to be taken at home and in the workplace:

• To prevent rodent ingress, cracks in walls and floors, as well as pipe penetrations, must be sealed.
• Food should be stored in sealed containers, and garbage must be disposed of regularly.
• If mice or rats are sighted indoors, professional rodent control services should be engaged.
• When opening spaces that have been closed for a prolonged period (e.g., summer houses, warehouses, cabins), one must ventilate the area for a minimum of 30 minutes prior to entry.

Precautions during cleaning:

• Rodent feces or urine must never be swept or vacuumed; such actions aerosolize viral particles.
• Contaminated areas should first be thoroughly wetted with water and a disinfectant (a 1:10 bleach solution is appropriate) and subsequently wiped with paper towels or a cloth.
• Gloves, FFP2/N95 standard masks, and protective eyewear must be utilized.
• Following cleaning, all utilized gloves and cloths must be disposed of in a sealed garbage bag, and hands must be washed thoroughly with copious amounts of soap and water.

Precautions in outdoor settings:

• During camping and nature hikes, food must be transported in sealed containers and not left exposed.
• Upon arrival at a cabin or summer house, bedding and upholstery should be inspected; if traces of rodents are present, the items must only be used post-cleaning.
• Masks and gloves are mandatory during agricultural and hayloft work.

When Should a Doctor be Consulted?

Medical attention should be sought without delay in the following scenarios:

• The development of sudden high fever, severe myalgia, and profound fatigue within 1 to 8 weeks in an individual with a history of rodent exposure.
• The onset of dyspnea, tachypnea, or cough in conjunction with the aforementioned symptoms (suspicion of HPS).
• HFRS indicators, such as a marked decrease in urine output, cutaneous bruising, or epistaxis.
• Influenza-like illness in individuals with a history of travel to South America or the Atlantic Ocean within the past 1-2 months (in the context of MV Hondius contact tracing).

How is Hantavirus Diagnosed?

Diagnosis is initiated upon clinical suspicion and subsequently corroborated by laboratory testing. The physician will primarily inquire about the patient's history of rodent exposure, occupational risk factors, and travel history. Differential diagnosis is of paramount importance, as the symptoms can mimic conditions such as influenza, leptospirosis, viral hemorrhagic fevers, and sepsis.

Primary diagnostic modalities:

• Serological testing (ELISA): Detection of IgM and IgG antibodies — this is the most frequently employed methodology.
• RT-PCR: Direct detection of viral RNA; particularly valuable during the acute phase of the disease.
• Complete Blood Count (CBC): Thrombocytopenia and leukocytosis are typical findings.
• Renal and hepatic function tests: Essential for the evaluation of HFRS.
• Chest Radiograph/CT scan: Utilized to demonstrate pulmonary edema in cases of suspected HPS.

Other Frequently Asked Questions

Is Hantavirus fatal?

Yes, hantavirus carries a significant risk of mortality, particularly when it presents as HPS (the pulmonary form); the mortality rate for this form is approximately 38%. The HFRS (renal form) clinical picture has a mortality rate ranging from 1% to 15%, depending on the specific viral strain. Early diagnosis and intensive care support markedly enhance the probability of survival.

Is there a Hantavirus vaccine?

There is currently no widely available hantavirus vaccine approved for use in Turkey, Europe, or the United States. National vaccines developed against certain HFRS strains are utilized locally in China and South Korea.

Is Hantavirus transmitted from person to person?

As a rule, hantaviruses are not transmitted from person to person. The only exception is the Andes strain, observed in South America; limited human-to-human transmission has been reported in scenarios involving very close and prolonged contact. This risk is non-existent for the strains present in Turkey.

Is the outbreak on the MV Hondius vessel a pandemic?

No. The World Health Organization declared on May 7, 2026, that the global public health risk is low and that this event does not mark the onset of a new COVID-like pandemic. Human-to-human transmission of the Andes strain is only possible through close and protracted contact.

What is the incubation period for Hantavirus?

The hantavirus incubation period varies between 1 and 8 weeks, contingent upon the viral strain; in the vast majority of cases, symptoms manifest within 2-4 weeks following exposure.

What should I do to protect myself from Hantavirus?

The foundation of prevention lies in rodent control: essential measures include thwarting mouse/rat ingress at home and in the workplace, storing food in sealed containers, thoroughly ventilating long-closed spaces prior to cleaning, wetting rodent feces with disinfectant prior to wiping rather than sweeping, and strictly utilizing masks and gloves in high-risk environments.

References

• World Health Organization (WHO) — Multi-country Hantavirus Cluster, Disease Outbreak News, May 2026
• European Centre for Disease Prevention and Control (ECDC) — Hantavirus-associated cluster of illness on a cruise ship, May 2026
• Africa CDC — Statement on Multi-Country Hantavirus Cluster, May 2026
• Turkish Ministry of Health, General Directorate of Public Health — Hantavirus Information Note
• CDC (Centers for Disease Control and Prevention) — About Hantavirus

Medical Disclaimer: This content is for informational purposes only and does not substitute for a professional medical examination. If you suspect you have been exposed to Hantavirus, please seek immediate medical attention at a healthcare facility.